The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Anuraag Gambhir
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The BSE received a disclosure under SEBI's Substantial Acquisition of Shares & Takeovers Regulations (Reg 29(1)) from Anuraag Gambhir related to Dr Lalchandani Labs Ltd. Such filings are typically made when an entity's shareholding crosses the 2% threshold in a financial year (creeping acquisition/disposal limit). The actual disclosure document content was not accessible (BSE page returned an error), so the direction of the transaction (acquisition or disposal) and the exact shareholding change cannot be determined from the available information.
Without the disclosure details, the specific impact on shareholders is unclear. Investors should check the full filing on BSE/NSE to see whether Anuraag Gambhir increased or reduced his stake, which would influence sentiment accordingly.